Janus Henderson Group PLC Rhythm Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,411,902 shares of RYTM stock, worth $151 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,411,902
              Previous 1,655,350
              
        
           14.71%
        
      
          
        Holding current value
$151 Million
            Previous $87.7 Million
            
        
           1.75%
        
      
          
        % of portfolio
0.05%
            Previous 0.05%
          
        Shares
	  31 transactions
	
  Others Institutions Holding RYTM
# of Institutions
252Shares Held
64.3MCall Options Held
210KPut Options Held
575K- 
    
      Black Rock Inc. New York, NY6.74MShares$722 Million0.01% of portfolio
- 
    
      Baker Bros. Advisors LP New York, NY5.6MShares$601 Million3.59% of portfolio
- 
    
      Ra Capital Management, L.P. Boston, MA5.56MShares$596 Million7.68% of portfolio
- 
    
      Primecap Management CO Pasadena, CA4.88MShares$523 Million0.25% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA3.59MShares$385 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.97B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...